Asia Pacific Real Estate Investment Surges 19 in Q1 India Emerges as Key Logistics and Data Centre Hub Savills Report Understanding IPOs A Comprehensive Guide to Initial Public Offerings Dow Jones Futures Edge Higher as SP 500 and Nasdaq Hit New Highs Earnings Movers Include Zscaler Modine Semtech Amazon UK Chief Urges Shift in Blaming Youth for Unemployment Points to Education System Gaps Tokenization Could Reshape Banking Landscape Strategys Michael Saylor Suggests Rising Bankruptcy in Singapore Overspending and Business Failures Drive Financial Distress VLRS Q1 2026 Earnings Narrower Loss Beats Expectations But Stock Declines SWIM Q1 2026 Earnings Surpasses EPS Estimates with 5272 Surprise AZTR Q1 2026 Earnings Significant EPS Miss Amidst EarlyStage Development Siebert Financial Corp SIEB Q4 2025 Earnings Modest Loss Reported Amidst Quiet Quarter JNJ Q1 2026 Earnings Narrow EPS Beat Signals Operational Resilience Amid Mixed Market Sentiment WLY Q1 2026 Earnings EPS Beats Estimates by 1167 FibroBiologics Inc FBLG Rallies 57 as Shares Test Key Resistance at 118 Ategrity Specialty Insurance ASIC Modestly Gains Approaching Key Resistance Blackrock MuniAssets Fund MUA Edges Higher in Tight Range as Yield Hunt Continues Armada Acquisition Corp II Warrant XRPNW Surges 14 Amid Speculative Trading Columbus Circle Capital Corp II CMII Holds Steady at 991 as Market Watches Key Levels Microsoft and Anthropic in Advanced Talks for Maia AI Chip Supply Deal After 5 Billion Investment eGain Corporation Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency Micropolis AI Robotics MCRP Gains 558 as Investors Eye Key Resistance Levels RRC Q1 2026 Earnings Strong EPS Beat Driven by Cost Discipline and Operational Efficiency PROV Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher GPI Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick ETR Q1 2026 Earnings Slight EPS Miss Amid Solid Utility Performance ZIONP Q1 2026 Earnings Preferred Shares React to Earnings Beat Despite Revenue Uncertainty CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses MDRR Q2 2021 Earnings BetterthanExpected Loss as Company Navigates Recovery